Similar articles

• The PAR2 signal peptide prevents premature receptor cleavage and activation.

  Liu B, Lee G, Wu J, Deming J, Kuei C, Harrington A, Wang L, Towne J, Lovenberg T, Liu C, Sun S. Liu B, et al. PLoS One. 2020 Feb 20;15(2):e0222685. doi: 10.1371/journal.pone.0222685. eCollection 2020. PLoS One. 2020. Retraction in: PLoS One. 2024 Jun 6;19(6):e0305363. doi: 10.1371/journal.pone.0305363. PMID: 32078628 Free PMC article. Retracted.
• Thrombin cleaves and activates the protease-activated receptor 2 dependent on thrombomodulin co-receptor availability.

  Heuberger DM, Franchini AG, Madon J, Schuepbach RA. Heuberger DM, et al. Thromb Res. 2019 May;177:91-101. doi: 10.1016/j.thromres.2019.02.032. Epub 2019 Feb 28. Thromb Res. 2019. PMID: 30861432
• Cathepsin S signals via PAR2 and generates a novel tethered ligand receptor agonist.

  Elmariah SB, Reddy VB, Lerner EA. Elmariah SB, et al. PLoS One. 2014 Jun 25;9(6):e99702. doi: 10.1371/journal.pone.0099702. eCollection 2014. PLoS One. 2014. PMID: 24964046 Free PMC article.
• Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.

  Shi X, Gangadharan B, Brass LF, Ruf W, Mueller BM. Shi X, et al. Mol Cancer Res. 2004 Jul;2(7):395-402. Mol Cancer Res. 2004. PMID: 15280447
• The signaling of protease-activated receptor-2 activating peptide-induced contraction in cat esophageal smooth muscle cells.

  Ha HS, Lee SE, Lee HS, Kim GH, Yoon CJ, Han JS, Lee JY, Sohn UD. Ha HS, et al. Arch Pharm Res. 2017 Dec;40(12):1443-1454. doi: 10.1007/s12272-017-0975-1. Epub 2017 Nov 2. Arch Pharm Res. 2017. PMID: 29098568